Developmental and reproductive toxicity studies on artemisone

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 86, Issue 2, 2009, Pages 131-143

  Schmuck, G ^a   Klaus, A M ^a   Krotlinger F ^a   Langewische, F W ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Developmental and reproductive toxicity; Embryo and fetotoxicity; Teratogenicity

Indexed keywords

ARTEMISININ DERIVATIVE; ARTEMISONE; BAY 44 9585; UNCLASSIFIED DRUG;

ABORTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS LUTEUM; DEVELOPMENTAL TOXICITY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO RESORPTION; ESTRUS; FEMALE; FERTILITY; FETAL WELL BEING; FETUS; HEART VENTRICLE SEPTUM DEFECT; INTRAUTERINE INSEMINATION; MALE; MOTOR ACTIVITY; NIDATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; REPRODUCTIVE TOXICITY; SURVIVAL; TOXICITY; WEIGHT GAIN;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTIMALARIALS; ARTEMISININS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EMBRYONIC DEVELOPMENT; FEMALE; FERTILITY; FETAL RESORPTION; GROWTH AND DEVELOPMENT; HEART SEPTAL DEFECTS, VENTRICULAR; HEMATOPOIESIS, EXTRAMEDULLARY; INFERTILITY, FEMALE; ORGAN SIZE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RABBITS; RATS; RATS, WISTAR; SPECIES SPECIFICITY; SPLEEN; SPLENOMEGALY;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 65549084038     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20192     Document Type: Article

References (20)

1. China Cooperative Research Group. 1982. Studies on the toxicity of qinghaosu and its derivative. J Trad Chin Med 2:31-38.
2. Clark RL, White TBK, Clode SA, Gaunt I, Winstanley P, Ward SA. 2004. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B 71:380-394.
3. Clark RL, Lerman SA, Cox EM, Gristwood WE, White TEK. 2008a. Developmental toxicity of artesunate in the rat: Comparison to other artemisinins, comparison of embryotoxicity kinetics by oral and intravenous routes, relationship to maternal reticulocyte count. Birth Defects Res B 83:397-06.
4. Clark RL, Arima A, Makori N, Nakata Y, Bernard E, Gristwood W, Harrell A, White TEK, Wier PJ. 2008b. Artesunate: Developmental toxicity and toxicokinetics in monkeys. Birth Defects Res B 83: 418-434.
5. Haynes RK, Krishna S. 2004. Artemisinins: Activities and actions. Microbes Infect 6:1339-1346.
6. Haynes R, Eugmann B, Stetter J, Riekmann K, Heilmann HD, Chan H-W, Cheung M-K, Lam W-L, Wong H-N, Croft SL, Vivas L, Rattray L, Stewart L, Peters W, Robinson BL, Edstein MD, Kotecka B, Kyle DE, Bermann B, Gerisch M, Radtke M, Schmuck G, Steinke W, Wollborn U, Schmeer K, Römer A. 2006. Artemifone: A highly active antimalarial drug of the artemisinin class. Angewandte Ghent 45/13:2082-2088.
7. ICH guideline. 2006. Detection of Toxicity to Reproduction for Medicinal Products. (CPMP 111/3387/93).
8. Kawamura S, Kato T, Matsuo M, Sasaki M, Katsuda Y, Hoberman AM, Yasuda M. 1995. Species differences in developmental toxicity of an N-phenylimide herbicide between rats and rabbits and sensitive period of toxicity to tat embryos. Congen Anomolies 35:123-132.
9. Kawamura S, Yoshioka T, Kato T, Matsuo M, Yasuda M. 1996. Histological changes in rat embryonic blood cells as a possible mechanism for ventricular septa] defects produced by N-phenylimide herbicide. Teratology 54:237-244.
10. Krishna S, Uhlemann A-C, Haynes RK. 2004. Artemisinins: Mechanism of action and potential for resistance. Drug Resist Updates 7:233-244.
11. Li Q, Si Y, Smith KS, Zeng Q, Weina PJ. 2008. Embryotoxicity of artesunate in animals species related to drug tissue distribution and toxicokinetic profiles. Birth Defects Res B 83:435-445.
12. Longo M, Zanoncelli S, Manera D, Brughera M, Colombo P, Lansen J, Mazue G, Gomes M, Taylor WRj, Olliaro P. 2006. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Reprod Toxicol 21:83-93.
13. McGrady R, Cho T, Keo NK, Thwai KL, Villegas L, Looareesuwan S, White NJ, Nosten F. 2001. Artemisinin antimalarials in pregnancy: A prospective treatment study of 539 pisodes of multidrug-resistant plasmodium falciparum. Clin Infect Dis 33:2009-2016.
14. Robert A, Gazelles J, Meunier B. 2001. Characterization of the alkylation product of heme by the antimalarial drug artemisinin. Angew Chem Int Ed Engl 40:1954-1957.
15. Selmeczi K, Robert A, Claparols C, Meunier B. 2004. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin. DEBS Lett 556:245-248.
16. Schmuck G, Haynes RK. 2000. Establishment of an in vitro screening, model for neurodegeneration induced by antmalarial drugs of the artemisinin-type. Neurotox Res 2:37-49.
17. Schmuck G, Rühl-Eehlert C, Klaus A-M, Eiben R. 2007. Artemisinin derivatives I. Classic examples in toxicologic pathology XTIT; Seminar of the ESTP and the PhD program at the university of veterinary medicine in Hannover (24-25 Feb. 2006) http://212.227.190.64/estp/dra2007ebe/schmuck2006/text.htm.
18. White TEK, Clark RL. 2008. Sensitive periods for developmental toxicity of orally administered artesunate in the rat. Birth Defects Res B 83:407-417.
19. White TEK, Bushdid PB, Ritter S, Laffan SB, Clark RL. 2006. Artesunate depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo. Birth Defects Res B 77:413-429.
20. World Health Organization. 2003. Assessment of the safety of artemisinin compounds in pregnancy. WHO/CDS/MAL/2003.1094; WHO/RBM/TDR/Artemisinin/03.1 (www.who.int/tdr/publications/publications/artem isinin-pregn.htm).